# Alanosine in Treating Patients With Cancer

> **NCT00062283** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Lung Cancer
- Malignant Mesothelioma
- Pancreatic Cancer
- Sarcoma

## Interventions

- **DRUG:** L-alanosine

## Key facts

- **NCT ID:** NCT00062283
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-12
- **Final completion:** 2009-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062283, "Alanosine in Treating Patients With Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00062283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*